Clinical Trial Update: Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating aprepitant for the prevention of chemotherapy-induced nausea and vomiting; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 3 | Status: UNKNOWN